title: New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis.
abstract: Modern technology has improved the ability to probe effectively the underlying biology of ALS by examination of genomic, proteomic and physiological changes in patients with ALS, as well as to monitor functional and structural changes during the course of disease. While effective treatments for ALS are lacking, the discovery of sensitive biomarkers to disease activity offers clinicians tools for rapid diagnosis and insights into the pathophysiology of ALS. The ultimate aim is to lessen reliance on clinical measures and survival as trial endpoints and broaden the therapeutic options for patients with this disease.
authors.affiliation: Department of Neurology, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan China.
authors.forename: Xueping
authors.initials: X
authors.lastname: Chen
authors.affiliation: Department of Neurology, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan China.
authors.forename: Hui-Fang
authors.initials: HF
authors.lastname: Shang